首页> 外文OA文献 >Optimization of Glucose oxidase towards oxygen independency and high mediator activity for amperometric glucose determination in diabetes analytics
【2h】

Optimization of Glucose oxidase towards oxygen independency and high mediator activity for amperometric glucose determination in diabetes analytics

机译:优化葡萄糖氧化酶的氧依赖性和高介体活性,可用于糖尿病分析中的安培血糖测定

摘要

Glucose oxidase is an oxidoreductase exhibiting a high β-D-glucose specificity and high stability which renders glucose oxidase well-suited for applications in diabetes care. Nevertheless, GOx activity is highly oxygen dependent which can lead to inaccuracies in amperometric β-D-glucose determinations. Therefore a directed evolution campaign with two rounds of random mutagenesis (SeSaM followed by epPCR), site saturation mutagenesis studies, and one simultaneous site saturation library (OmniChange; 4 positions) was performed in the first project part. A for diabetes care well suited mediator (quinone diimine) was selected and the GOx variant (T30V I94V) served as starting point. Two iterative rounds of random diversity generation and screening yielded two subsets of amino acid positions which mainly improved activity (A173, A332) and oxygen independency (F414, V560). Simultaneous site saturation of all four positions with a reduced subset of amino acids using the OmniChange method yielded finally variant V7 with a 37-fold decreased oxygen dependency (mediator activity: 7.4 U/mg WT, 47.5 U/mg V7; oxygen activity: 172.3 U/mg WT, 30.1 U/mg V7). V7 is still highly β-D-glucose specific, highly active with the quinone diimine mediator and thermal resistance is retained (prerequisite for GOx coating of diabetes test stripes). The latter properties and V7’s oxygen insensitivity make V7 a very promising candidate to accomplish the main challenge in diabetes analytics by combining high glucose specificity with oxygen independency. In the second project part, the influence of residue 414 on the interaction of small soluble mediator compounds and GOx were investigated. A site saturation experiment revealed a subset of amino acids (Y, M, L, V) which change the preference of GOx from the QDM-1 to the more polar and sterically more demanding QDM-2. The substitution I414Y resulted in a 4.8-fold increased activity of V7 employing the QDM-2 system, what was traced back to a higher affinity through the change to a more polar residue and structural reorganization. Furthermore, it was shown that substitutions of residue 414 also influence the activity employing ferrocenemethanol, a prominent mediator example for GOx. Molecular docking studies revealed that small water soluble mediator compounds bind directly in the active site of GOx in close vicinity to residue 414. First time an enzyme was adapted to a specific mediator component by protein engineering. This approach might not only play an important role in diagnostics but also in the field of bio-fuel cells in order to adopt electron donor or acceptor enzymes to electrode systems. In the last project part a bio-process was established in order to ensure a fast and efficient production of GOx for characterization studies. Media screening and investigations of the feeding strategy revealed a batch fermentation process with a process time of 48 h. The fermentation process was characterized with respect to bio-mass formation, glucose consumption, respiratory properties (RQ, pO2), acetate formation and GOx formation. A downstream process was scaled-up for the handling of 10 to 20 L of cell broth. Tangential flow filtration was introduced for the cell harvest (micro-filtration) and product isolation (ultra-filtration) in order to handle the respective volumes. The optimization of an anion-exchange chromatography step resulted in a downstream process with only one purification step. Samples with a GOx-content higher 90 % could be reached.
机译:葡萄糖氧化酶是表现出高β-D-葡萄糖特异性和高稳定性的氧化还原酶,这使得葡萄糖氧化酶非常适合用于糖尿病护理中。然而,GOx活性高度依赖氧,这可能导致安培性β-D-葡萄糖测定的不准确。因此,在第一个项目部分中,进行了两轮随机诱变(SeSaM,然后进行epPCR),位点饱和诱变研究和一个同时位点饱和文库(OmniChange; 4个位置)的定向进化活动。选择了一个适合糖尿病治疗的媒介(醌二亚胺),以GOx变体(T30V I94V)作为起点。随机多样性生成和筛选的两个迭代回合产生了两个氨基酸位置子集,主要改善了活性(A173,A332)和氧独立性(F414,V560)。使用OmniChange方法同时用氨基酸减少的子集对所有四个位置同时进行位点饱和,最终产生变异株V7,其氧依赖性降低了37倍(介体活性:7.4 U / mg WT,47.5 U / mg V7;氧活性:172.3 U / mg WT,30.1 U / mg V7)。 V7仍具有很高的β-D-葡萄糖特异性,与醌二亚胺介体具有很高的活性,并保留了耐热性(糖尿病测试条的GOx涂层的前提)。后者的特性和V7对氧气的不敏感性,使V7通过将高葡萄糖特异性和氧气独立性相结合,成为完成糖尿病分析中主要挑战的非常有希望的候选者。在第二个项目部分中,研究了残留物414对小的可溶性介体化合物与GOx相互作用的影响。一个位点饱和实验显示了一部分氨基酸(Y,M,L,V),这些氨基酸将GOx的优先级从QDM-1更改为极性更大,空间要求更高的QDM-2。使用QDM-2系统,取代I414Y导致V7的活性增加了4.8倍,这可以追溯到通过改变极性更强的残基和结构重组获得更高的亲和力。此外,已经表明,残基414的取代也影响使用二茂铁甲醇(GOx的重要介体实例)的活性。分子对接研究表明,小的水溶性介体化合物直接在GOx的活性位点与残基414紧密结合。第一次通过蛋白质工程使酶适应特定介体成分。为了在电极系统中采用电子供体或受体酶,这种方法可能不仅在诊断中起重要作用,而且在生物燃料电池领域也可能起重要作用。在最后一个项目部分中,建立了生物过程,以确保快速高效地生产用于表征研究的GOx。媒体筛选和喂养策略研究表明,分批发酵过程的处理时间为48小时。发酵过程的特征在于生物量形成,葡萄糖消耗,呼吸特性(RQ,pO2),乙酸盐形成和GOx形成。扩大了下游工艺以处理10至20 L的细胞肉汤。引入切向流过滤用于细胞收获(微滤)和产物分离(超滤),以处理各自的体积。阴离子交换色谱步骤的优化导致仅需一个纯化步骤的下游过程。可以达到GOx含量高于90%的样品。

著录项

  • 作者

    Arango Gutierrez Erik Uwe;

  • 作者单位
  • 年度 2015
  • 总页数
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号